Implantica AG Stock
Stocks
IMP A SDB
SE0014855029
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 66.90 SEK | -2.19% |
|
-0.30% | +33.53% |
| 11-05 | Implantica performs first RefluxStop surgeries in the US | FW |
| 10-27 | Implantica prepares for first RefluxStop surgeries in the US | FW |
| Market Cap | 419M 463M 388M 350M 659M 43.62B 683M 4.66B 1.85B 23.3B 1.74B 1.7B 73.97B | P/E 2026 * |
-20.2x | P/E 2027 * | -16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 391M 432M 362M 326M 615M 40.71B 637M 4.35B 1.72B 21.74B 1.62B 1.59B 69.02B | EV / Sales 2026 * |
114x | EV / Sales 2027 * | 45.7x |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IMP A SDB | Delayed | |
Deutsche Boerse AG
| 8IM1 | Delayed | |
|
Börse Stuttgart
| 8IM1 | Delayed | |
|
Tradegate
| 8IM1 | Real-time | |
|
Boerse Muenchen
| 8IM1 | Real-time |
Last Transcript: Implantica AG
| 1 day | -2.19% | ||
| 1 week | -0.30% | ||
| Current month | -2.05% | ||
| 1 month | +6.87% | ||
| 3 months | +24.81% | ||
| 6 months | +58.91% | ||
| Current year | +33.53% |
| 1 week | 65.7 |  | 68.7 |
| 1 month | 60.5 | | 71 |
| Current year | 38 | | 80.3 |
| 1 year | 38 | | 80.3 |
| 3 years | 16.46 | | 86.4 |
| 5 years | 15.4 | | 86.4 |
| 10 years | 15.4 | | 178.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Forsell
CEO | Chief Executive Officer | 72 | 2014-12-31 |
Andreas Öhrnberg
DFI | Director of Finance/CFO | 48 | 2019-12-31 |
| Corporate Officer/Principal | 69 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Liselott Kilaas
CHM | Chairman | 67 | 2019-12-31 |
Johan Bojs
BRD | Director/Board Member | 62 | 2019-12-31 |
Tomas Puusepp
BRD | Director/Board Member | 71 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/31/26 | Buy | Chairman | 28,135 | 0.0484% | ||
| 9/24/25 | Sell | Chief Financial Officer | 16,700 | 0.0287% | ||
| 9/24/25 | Sell | Chief Financial Officer | 17,100 | 0.0294% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.19% | -0.30% | +15.74% | +302.04% | 475M | |
| +1.18% | -1.28% | -16.05% | +13.29% | 186B | |
| +1.85% | +1.04% | +6.99% | +42.70% | 124B | |
| -0.88% | -4.98% | -17.08% | +9.86% | 119B | |
| +1.36% | -5.91% | -43.00% | +3.16% | 91.43B | |
| +2.96% | +7.64% | -1.76% | +80.54% | 66.67B | |
| +1.08% | +2.90% | +12.95% | -7.56% | 58.76B | |
| +0.89% | +4.17% | +0.39% | +62.87% | 54.99B | |
| -0.68% | +6.83% | -1.64% | +55.26% | 49.93B | |
| -1.28% | -0.43% | - | - | 35.13B | |
| Average | +0.15% | -1.73% | -4.83% | +62.46% | 79B | |
| Weighted average by Cap. | +0.45% | -3.32% | -9.98% | +27.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.43M 3.79M 3.18M 2.87M 5.4M 357M 5.59M 38.15M 15.13M 191M 14.22M 13.92M 606M | 9.14M 10.09M 8.46M 7.63M 14.38M 952M 14.89M 102M 40.29M 508M 37.87M 37.07M 1.61B |
| Net income | -20.78M -22.93M -19.22M -17.34M -32.68M -2.16B -33.83M -231M -91.54M -1.15B -86.04M -84.21M -3.67B | -25.61M -28.26M -23.69M -21.37M -40.27M -2.66B -41.69M -285M -113M -1.42B -106M -104M -4.52B |
| Net Debt | -28.02M -30.93M -25.92M -23.39M -44.07M -2.92B -45.63M -311M -123M -1.56B -116M -114M -4.94B | -1.71M -1.88M -1.58M -1.42M -2.68M -178M -2.78M -18.97M -7.52M -94.88M -7.07M -6.92M -301M |
Employees
-
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | SEK 66.90 | -2.19% | 10,066 |
| 26-11-12 | SEK 68.40 | +2.09% | 33,551 |
| 26-11-11 | SEK 67.00 | +1.21% | 18,199 |
| 26-11-10 | SEK 66.20 | -0.15% | 17,527 |
| 26-11-09 | SEK 66.30 | -1.19% | 24,766 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
6.021EUR
Average target price
8.141EUR
Spread / Average Target
+35.21%
- Stock Market
- Stocks
- IMP A SDB Stock
Select your edition
All financial news and data tailored to specific country editions
